AZT (Zidovudine, Retrovir): News
- FDA Approves Generic Formulations of Lamivudine and Zidovudine Tablets and Nevirapine Tablets and Oral Suspension (May 25, 2012)
From U.S. Food and Drug Administration
- Generic Drug Maker Receives FDA, PEPFAR Approval for Drug to Treat HIV-Positive Children (March 14, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Retrovir (Zidovudine) for Pediatrics (January/February 2010)
In Positively Aware, from Test Positive Aware Network
- New Dosing Recommendations Retrovir (Zidovudine) Syrup for HIV-Infected Infants (November 6, 2009)
From U.S. Food and Drug Administration
- GlaxoSmithKline Announces New Program to Provide Financial Assistance for Eligible HIV Patients in the U.S. (November 11, 2008)
If you live in the United States, use private health insurance and take Combivir (AZT/3TC), Epzicom (abacavir/3TC, Kivexa), Lexiva (fosamprenavir, Telzir) or another HIV drug made by GlaxoSmithKline, you may have a chance to save a nice chunk of change.
From GlaxoSmithKline
- FDA Approves First Generic HIV/AIDS Drug in Capsule Form for United States Market (March 31, 2006)
From U.S. Food and Drug Administration
- A Bitter-Sweet Pill (March 2006)
The first ever HIV drug, AZT, has a checkered history. What's next for the drug as it comes off patent in the UK?.
From Positive Nation
- FDA Approves Four Generic Forms of Zidovudine for U.S. Sales After Retrovir's Patent Expires (September 21, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- GlaxoSmithKline's Patent on Retrovir Expires; Generic Versions of AZT Expected to Be Available Soon (September 20, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Zidovudine Generic Oral Solution Approved in United States (September 20, 2005)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Aurobindo Receives Tentative FDA Approval to Produce Generic Pediatric Version of AZT (Retrovir) for PEPFAR (September 12, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- FDA Grants Tentative Approval for First Generic Version of AZT for Use in Developing World (July 15, 2005)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- WHO Removes Cipla's Lamivudine, Zidovudine Generics From Approved Drug List (June 16, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Chinese Government Approves Sale of a Domestic AIDS Drug (August 13, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Simplified AZT Regimen Cuts Maternal-Infant Transmission in Half (March 6, 1998)
In AIDS Treatment News, from AIDS Treatment News
- The Problem With AZT (Spring 1998)
In Women Alive Newsletter, from Women Alive
- AZT in New Strength (Spring 1997)
In Women Alive Newsletter, from Women Alive
- Dethroning AZT (February 1997)
In GMHC Treatment Issues, from Gay Men's Health Crisis
- AZT Twice-Daily Tablets Approved; Dosing Concerns (November 15, 1996)
In AIDS Treatment News, from AIDS Treatment News
- AZT, ddI, and ddC Combinations at FDA Advisory Hearing (April 5, 1996)
In AIDS Treatment News, from AIDS Treatment News
- Recommendations of the U.S. Public Health Service Task Force on the Use of Zidovudine to Reduce Perinatal Transmission of HIV
|
Advertisement
|
Email
Glossary
